Harmony Days Sales Outstanding from 2010 to 2024

HRMY Stock  USD 35.13  0.46  1.33%   
Harmony Biosciences Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding will likely drop to 44.17 in 2024. During the period from 2010 to 2024, Harmony Biosciences Days Sales Outstanding regression line of annual values had r-squared of  0.67 and arithmetic mean of  187.95. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
46.49497785
Current Value
44.17
Quarterly Volatility
104.11479458
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Harmony Days Sales Outstanding Regression Statistics

Arithmetic Mean187.95
Geometric Mean145.21
Coefficient Of Variation55.40
Mean Deviation94.82
Median259.06
Standard Deviation104.11
Sample Variance10,840
Range217
R-Value(0.82)
Mean Square Error3,835
R-Squared0.67
Significance0.0002
Slope(19.08)
Total Sum of Squares151,758

Harmony Days Sales Outstanding History

2024 44.17
2023 46.49
2022 45.63
2021 41.64
2020 50.67

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 46.49  44.17 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.